Currency: CNY
Period
Q1 FY2024 Earnings
--
57.21M
0.23
Strong Buy
Jul 22, 2024
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Medprin Regenerative Medical Technologies: 2024 Interim Performance Forecast
Jul 17 06:22 ET
Maipu Medical: Report for the first quarter of 2024
Apr 24 12:00 ET
Maipu Medicine: 2023 Annual Report
Apr 18 12:00 ET
Maipu Medicine: 2023 Annual Report Summary
Read more
Updated: Jul 22, 2024
Buy
Hold
Underperform
Sell
No Data